Inmune Bio, Inc. - 8-K Filing

Inmune Bio received $4.6 million in R&D rebates from Australia and the UK, strengthening its balance sheet (Items: 8.01 Other Events, 9.01 Financial statements and Exhibits (d) Exhibits)

SEC EDGAR ·

Tickers: $INMB

Read the full article at SEC EDGAR

More Regulatory news